21 Diciembre 2021, USD/JPY
USDJPY trading plan:
Moderna Inc said that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant of the coronavirus in laboratory testing and that the current version of the shot would continue to be its "first line of defense against Omicron." Moderna said it still plans to develop a vaccine to protect against Omicron specifically and hopes to start clinical trials early next year. The company said a two-dose course of its vaccine generated low neutralizing antibodies against the Omicron variant, but a 50-microgram booster dose increased neutralizing antibodies against the variant 37-fold. A 100-microgram booster - the same strength as the original shots - drove neutralizing antibodies to more than 80 times pre-boost levels. This is a good signal for the stock market and USDJPY, which has a correlation with the shares.
Investment idea: buy 113.65 and take profit 114.14.
en 
id 
ar 
ru 
vn 
pt 
th 
kz 
ua 
tj 
uz 
az 
ms 